bpc-157 bio-available 10mg – NewBioRx BPC-157 10mg TB-500 10mg Blend

Protocol planning Proper cycle planning involves considering: Duration: typically 6-12 weeks for initial protocols Dose progression: some researchers start lower and titrate up Assessment points: evaluate at weeks 4, 8, 12 Follow-up: monitor for persistence of benefits after stopping Subsequent cycles: if benefits fade, when to repeat

Patient Education / Summary The following summary is intended for use in patient-facing materials, care coordination notes, and health literacy communications consistent with ADA 2026 Standards of Care, Section 5 (Facilitating Positive Health Behaviors)

[5] BPC-157 is stable at room temperature and bioavailable in rodent models when administered IM or IV

Add 2mL to a 10mg vial for 5mg/mL (5,000mcg/mL): 250mcg = 5 units, 500mcg = 10 units

Proteomics Clin Appl 11(1112):1700066